In this video interview, Rajesh R. Tampi, MD, discusses how a new FDA-approved medication may fit into the treatment landscape for agitation associated with Alzheimer disease.
In this episode of Nutrition 411, Summer Kessel, RD, CSOWM, shares how her personal experience with GLP-1 therapy transformed her understanding of food noise, appetite regulation, and sustainable behavior...
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
GLP-1 medications are reshaping patient expectations. In this podcast, learn how dietitians guide safe, evidence-based care amid rising demand and misinformation.
In this Nutrition 411 podcast, experts unpack the updated pyramid, highlighting minimal changes and how dietitians can address confusion and misinformation.
In this video interview, Sean Rose, MD, a pediatric neurologist at Nationwide Children’s Hospital and The Ohio State University, discusses new research examining how frequently children younger than 6 years...
Lisa Jones, MA, RDN, LDN, FAND; Bonnie Chambers, MSN, FNP-C
This episode of Nutrition411 explores how clinicians and dietitians can set realistic, emotionally informed expectations for patients using GLP-1 medications for obesity.
